Drugs / CG-750
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05345912 | Dec 2019 → Sep 2020 | — | CrystalGenomics, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CG-750 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05345912 ↗ |
| Route | Oral | “Administered orally” NCT05345912 ↗ |